You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 6, JUNE 1940 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PURPURA HAEMORRHAGICA FOLLOWING NEOARSPHENAMINE AND BISMARSEN THERAPY

FURTHER STUDIES ON SENSITIVITY TO ARSPHENAMINE AND TOLERANCE TO MAPHARSEN

ERNEST H. FALCONER, M.D.; NORMAN N. EPSTEIN, M.D.

Arch Intern Med. 1940;65(6):1158-1177.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1936 studies on 3 patients with purpura haemorrhagica following neoarsphenamine therapy were reported.1 We ascertained by experiments that 2 of these patients were very sensitive to neoarsphenamine but apparently not sensitive to mapharsen, as the intravenous injection of this arsphenamine derivative failed to produce any significant effects on the platelets and capillaries or any untoward constitutional reaction. The third patient of the series disappeared from observation after leaving the hospital; hence no experimental studies were made.

Since publication of the report mentioned, we have had an opportunity to study 6 additional patients who showed hemorrhagic phenomena following the therapeutic use of arsphenamine derivatives. It appeared to us important to record our experimental studies on these patients, particularly those on 5 patients of the series who showed typical purpura haemorrhagica following the use of neoarsphenamine or of bismarsen but who had no apparent reaction following the intravenous injection of . . . [Full Text PDF of this Article]


Author Affiliations

SAN FRANCISCO

From the Divisions of Medicine and Dermatology of the University of California Medical School.


Footnotes

Supported by a grant from the Christine Breon Fund.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1940 American Medical Association. All Rights Reserved.